AI Healthcare: Drug Discovery and Development

Jamie’s the CEO and Co-founder of Conduit who are building the end-to-end data platform to set up and run machine learning analytics for drug discovery 10x faster than current methods. He’s a scientist and consultant turned entrepreneur and believes that insights from data should be incredibly accessible for researchers and that value should flow back to the knowledge generators.

Andrew is the Digital Chemistry lead at GSK, overseeing the transformation of technologies, data, and computational applications for discovery medicinal chemistry. With a decade working across small molecule discovery projects and in attrition reduction, he advocates for translational data capture and reuse in both programme and portfolio analytics. He cares about judicious deployment of conventional and cutting-edge tools to bring about the greatest difference to real-world projects.